| abstract |
A series of compounds represented by the structural formulas, for example (see above formula) and pharmaceutically acceptable isomers, salts, solvates and polymorphs thereof are disclosed. Also disclosed are pharmaceutical compositions containing said compounds and their u 3e as thrombin receptor antagonists and binders to cannabinoid receptors. |